Page last updated: 2024-12-05

5-iodocytosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

5-iodocytosine is a synthetic nucleoside analog that has been studied for its potential as an antiviral and anticancer agent. It is a modified form of cytosine, a naturally occurring nucleobase, with an iodine atom attached at the 5-position. Its antiviral properties stem from its ability to inhibit DNA polymerase, an enzyme essential for viral replication. 5-iodocytosine has been shown to be effective against a range of viruses, including herpes simplex virus and cytomegalovirus. In cancer research, 5-iodocytosine is investigated for its potential to act as a prodrug that can be converted into a cytotoxic agent within cancer cells. This targeted approach aims to minimize damage to healthy cells. Further research is needed to fully explore the therapeutic potential of 5-iodocytosine for both viral and cancer treatment.'

5-iodocytosine: RN given refers to unlabeled cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14281
SCHEMBL ID8815
MeSH IDM0051728

Synonyms (34)

Synonym
4-amino-5-iodo-2(1h)-pyrimidinone
AG-690/12885355
4-amino-5-iodo-2-pyrimidinol
5-iodocytosine
cytosine, 5-iodo-
6-amino-5-iodo-1h-pyrimidin-2-one
1122-44-7
6-amino-5-iodo-1h-pyrimidin-2-one;6-amino-5-iodopyrimidin-2(1h)-one
A802519
4-amino-5-iodo-1,2-dihydropyrimidin-2-one
6-amino-5-iodopyrimidin-2(1h)-one
2(1h)-pyrimidinone,6-amino-5-iodo-
AKOS015919517
AKOS015998182
4-amino-5-iodopyrimidin-2(1h)-one
FT-0633363
4-amino-5-iodo-1h-pyrimidin-2-one
4-amino-2-hydroxy-5-iodopyrimidine
TD8031
AM84340
CS-M0719
SCHEMBL8815
W-200838
2(1h)-pyrimidinone, 4-amino-5-iodo-
4-amino-5-iodopyrimidinone
AC-25656
AKOS025117166
mfcd00023162
DTXSID40149947
SY021694
AS-19496
5-odocytosine
SB55521
EN300-719480
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's2 (20.00)18.2507
2000's4 (40.00)29.6817
2010's1 (10.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]